In thyroid cancer, NR2F1-AS1 promotes proliferation and inhibits apoptosis via the miR-338-3p/CCND1 and miR-423-5p/SOX12 pathways [36, 37]. Here, NR2F1 is linked to thyroid gland carcinoma.